182 related articles for article (PubMed ID: 15105133)
1. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Barnard DL; Hubbard VD; Smee DF; Sidwell RW; Watson KG; Tucker SP; Reece PA
Antimicrob Agents Chemother; 2004 May; 48(5):1766-72. PubMed ID: 15105133
[TBL] [Abstract][Full Text] [Related]
2. An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Watson KG; Brown RN; Cameron R; Chalmers DK; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell DB; Reece PA; Ryan J; Stanislawski PC; Tucker SP; Wu WY; Barnard DL; Sidwell RW
J Med Chem; 2003 Jul; 46(15):3181-4. PubMed ID: 12852746
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
[TBL] [Abstract][Full Text] [Related]
6. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
[TBL] [Abstract][Full Text] [Related]
7. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.
Tijsma A; Franco D; Tucker S; Hilgenfeld R; Froeyen M; Leyssen P; Neyts J
Antimicrob Agents Chemother; 2014 Nov; 58(11):6990-2. PubMed ID: 25199773
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
[TBL] [Abstract][Full Text] [Related]
11. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species.
Lanko K; Sun L; Froeyen M; Leyssen P; Delang L; Mirabelli C; Neyts J
Antiviral Res; 2021 Nov; 195():105177. PubMed ID: 34517053
[TBL] [Abstract][Full Text] [Related]
13. [In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
Tonew M; Tonew E; Oehring H; Schmidt J
Virologie; 1985; 36(2):111-7. PubMed ID: 2994289
[TBL] [Abstract][Full Text] [Related]
14. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
[TBL] [Abstract][Full Text] [Related]
15. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
16. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones.
Chern JH; Lee CC; Chang CS; Lee YC; Tai CL; Lin YT; Shia KS; Lee CY; Shih SR
Bioorg Med Chem Lett; 2004 Oct; 14(20):5051-6. PubMed ID: 15380197
[TBL] [Abstract][Full Text] [Related]
18. Stabilisation of poliovirus with pirodavir.
Rombaut B; Andries K; Boeyé A
Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antipicornavirus activity of some phenoxypyridinecarbonitriles.
Kenny MT; Dulworth JK; Torney HL
Antimicrob Agents Chemother; 1985 Dec; 28(6):745-50. PubMed ID: 2417545
[TBL] [Abstract][Full Text] [Related]
20. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
